Health
COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark – BioSpace
Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.
Patients in a Phase II trial have begun receiving Modernas vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced. The modified vaccine, mRNA-1273.351, is being tested out of an abundance of caution, despite the fact that previous data has shown that the companys marketed mRNA-1273 vaccine produces neutralizing titers against all relevant variations, the company said.
Similarly inspired by caution, Denmark announced it is temporarilystopping vaccinations with…
-
General24 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News14 hours agoTips to improve engagement – Proctor